Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    June 2022
  1. BHANUPRAKASH V, Hosamani M, Venkatesan G, Singh RK, et al
    Long-term protective immunity to goatpox in goats after a single immunization with a live attenuated goatpox vaccine.
    Arch Virol. 2022 Jun 26. pii: 10.1007/s00705-022-05505.
    PubMed     Abstract available


  2. DAHER-NASHIF S, Al-Anany R, Ali M, Erradi K, et al
    COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Arch Virol. 2022 Jun 20. pii: 10.1007/s00705-022-05495.
    PubMed     Abstract available


    May 2022
  3. PIERI M, Nicolai E, Nuccetelli M, Sarubbi S, et al
    Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies.
    Arch Virol. 2022;167:1285-1291.
    PubMed     Abstract available


    April 2022
  4. BIN UMAIR M, Akusa FN, Kashif H, Seerat-E-Fatima, et al
    Viruses as tools in gene therapy, vaccine development, and cancer treatment.
    Arch Virol. 2022 Apr 24. pii: 10.1007/s00705-022-05432.
    PubMed     Abstract available


    February 2022
  5. OZ ME, Torlak E
    A high-resolution melting assay to differentiate a peste des petits ruminants virus vaccine strain from field isolates in Turkey.
    Arch Virol. 2022 Feb 11. pii: 10.1007/s00705-022-05386.
    PubMed     Abstract available


  6. ZHOU J, Li C, Tang A, Li H, et al
    Immunogenicity of an inactivated novel goose parvovirus vaccine for short beak and dwarfism syndrome in Cherry Valley ducks.
    Arch Virol. 2022 Feb 11. pii: 10.1007/s00705-021-05352.
    PubMed     Abstract available


  7. LI H, Ge Z, Luo Q, Fu Q, et al
    A highly pathogenic Marek's disease virus isolate from chickens immunized with a bivalent vaccine in China.
    Arch Virol. 2022 Feb 7. pii: 10.1007/s00705-021-05355.
    PubMed     Abstract available


    January 2022
  8. COKCALISKAN C, Tuncer-Goktuna P, Sareyyupoglu B, Turkoglu T, et al
    Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle.
    Arch Virol. 2022 Jan 16. pii: 10.1007/s00705-021-05273.
    PubMed     Abstract available


    December 2021
  9. ZHAO W, Zhang P, Bai S, Lv M, et al
    Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice.
    Arch Virol. 2021;166:3333-3341.
    PubMed     Abstract available


    October 2021
  10. JANG Y, Seo SH
    H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses.
    Arch Virol. 2021 Oct 25. pii: 10.1007/s00705-021-05284.
    PubMed     Abstract available


  11. KIM SC, Jeong CG, Park GS, Park JY, et al
    Temporal lineage dynamics of the ORF5 gene of porcine reproductive and respiratory syndrome virus in Korea in 2014-2019.
    Arch Virol. 2021;166:2803-2815.
    PubMed     Abstract available


  12. FAWZY M, Khairy GM, Hesham A, Rabaan AA, et al
    Nanoparticles as a novel and promising antiviral platform in veterinary medicine.
    Arch Virol. 2021;166:2673-2682.
    PubMed     Abstract available


    September 2021
  13. TANG P, Cui E, Song Y, Yan R, et al
    Porcine deltacoronavirus and its prevalence in China: a review of epidemiology, evolution, and vaccine development.
    Arch Virol. 2021 Sep 15. pii: 10.1007/s00705-021-05226.
    PubMed     Abstract available


  14. DONG S, Huang D, Wang Z, Zhang G, et al
    Clinical and molecular epidemiological characterization of rotavirus infections in children under five years old in Shandong province, China.
    Arch Virol. 2021;166:2479-2486.
    PubMed     Abstract available


    August 2021
  15. ENSOLI B, Moretti S, Borsetti A, Maggiorella MT, et al
    New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.
    Arch Virol. 2021 Aug 14. pii: 10.1007/s00705-021-05158.
    PubMed     Abstract available


    July 2021
  16. LIU J, Zhang P, Chen Y, Zhong W, et al
    Vaccination with virus-like particles of atypical porcine pestivirus inhibits virus replication in tissues of BALB/c mice.
    Arch Virol. 2021 Jul 28. pii: 10.1007/s00705-021-05185.
    PubMed     Abstract available


  17. UPRETY T, Wang D, Li F
    Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development.
    Arch Virol. 2021 Jul 3. pii: 10.1007/s00705-021-05142.
    PubMed     Abstract available


  18. MIRZAEI R, Attar A, Papizadeh S, Jeda AS, et al
    The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
    Arch Virol. 2021;166:1819-1840.
    PubMed     Abstract available


    May 2021
  19. GAO Y, Li P, Ma X, Bai X, et al
    The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.
    Arch Virol. 2021 May 18. pii: 10.1007/s00705-021-05100.
    PubMed     Abstract available


  20. GOMEZ-ROMERO N, Velazquez-Salinas L, Ridpath JF, Verdugo-Rodriguez A, et al
    Detection and genotyping of bovine viral diarrhea virus found contaminating commercial veterinary vaccines, cell lines, and fetal bovine serum lots originating in Mexico.
    Arch Virol. 2021 May 10. pii: 10.1007/s00705-021-05089.
    PubMed     Abstract available


  21. SARKER S, Athukorala A, Bowden TR, Boyle DB, et al
    Characterisation of an Australian fowlpox virus carrying a near-full-length provirus of reticuloendotheliosis virus.
    Arch Virol. 2021;166:1485-1488.
    PubMed     Abstract available


    April 2021
  22. BAZID AI, El-Alfy HA, El-Didamony G, Elfeil WK, et al
    Adjuvant effect of saponin in an oil-based monovalent (serotype O) foot-and-mouth disease virus vaccine on the antibody response in guinea pigs and cattle.
    Arch Virol. 2021 Apr 19. pii: 10.1007/s00705-021-05043.
    PubMed     Abstract available


    March 2021
  23. VERMA J, Subbarao N
    A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.
    Arch Virol. 2021;166:697-714.
    PubMed     Abstract available


    February 2021
  24. GRESLEHNER GP
    The vaccinologist's "dirty little secret": a better understanding of structure-function relationships of viral immunogens might advance rational HIV vaccine design.
    Arch Virol. 2021 Feb 19. pii: 10.1007/s00705-021-04982.
    PubMed     Abstract available


  25. UVERSKY VN
    On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder.
    Arch Virol. 2021 Feb 19. pii: 10.1007/s00705-021-04984.
    PubMed     Abstract available


  26. AFCHANGI A, Latifi T, Jalilvand S, Marashi SM, et al
    Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins.
    Arch Virol. 2021 Feb 3. pii: 10.1007/s00705-021-04964.
    PubMed     Abstract available


    January 2021
  27. ANDRIEU JM, Lu W
    Evidence of a tolerogenic vaccine against AIDS in the Chinese macaque prefigures a potential human vaccine.
    Arch Virol. 2021 Jan 28. pii: 10.1007/s00705-020-04935.
    PubMed     Abstract available


  28. LI J, Gao JJ, Li N, Wang YW, et al
    Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions.
    Arch Virol. 2021 Jan 24. pii: 10.1007/s00705-021-04960.
    PubMed     Abstract available


  29. ALLKOFER A, Garvey M, Ryan E, Lyons R, et al
    Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.
    Arch Virol. 2021 Jan 7. pii: 10.1007/s00705-020-04846.
    PubMed     Abstract available


  30. SABBAGHI A, Zargar M, Zolfaghari MR, Motamedi-Sedeh F, et al
    Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.
    Arch Virol. 2021 Jan 6. pii: 10.1007/s00705-020-04900.
    PubMed     Abstract available


  31. OZAN E, Muftuoglu B, Sahindokuyucu I, Kurucay HN, et al
    Marek's disease virus in vaccinated poultry flocks in Turkey: its first isolation with molecular characterization.
    Arch Virol. 2021 Jan 6. pii: 10.1007/s00705-020-04943.
    PubMed     Abstract available


    November 2020
  32. VAN REGENMORTEL MHV
    What does it mean to develop an HIV vaccine by rational design?
    Arch Virol. 2020 Nov 29. pii: 10.1007/s00705-020-04884.
    PubMed     Abstract available


  33. ALAGARASU K, Kakade MB, Bachal RV, Bote M, et al
    Use of whole blood over plasma enhances the detection of dengue virus RNA: possible utility in dengue vaccine trials.
    Arch Virol. 2020 Nov 27. pii: 10.1007/s00705-020-04892.
    PubMed     Abstract available


  34. SHAMIM S, Khan M, Kharaba ZJ, Ijaz M, et al
    Potential strategies for combating COVID-19.
    Arch Virol. 2020;165:2419-2438.
    PubMed     Abstract available


    October 2020
  35. CHEN L, Xiang B, Hong Y, Li Q, et al
    Phylogenetic analysis of infectious bronchitis virus circulating in southern China in 2016-2017 and evaluation of an attenuated strain as a vaccine candidate.
    Arch Virol. 2020 Oct 16. pii: 10.1007/s00705-020-04851.
    PubMed     Abstract available


    August 2020
  36. FOUAD HM, Ahmed A, Reyad EM, ElSadek SM, et al
    Hepatitis D virus seroprevalence in Egyptian HBsAg-positive children: a single-center study.
    Arch Virol. 2020 Aug 3. pii: 10.1007/s00705-020-04757.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: